Asia Pacific DTx Leadership Alliance
Introduction to DTx
Digital Therapeutics (DTX) refers to therapeutic interventions made possible by patient directed, clinically assessed software applications to better the process of identifying, treating, managing, and/or preventing diseases.
A growing need for cutting-edge healthcare solutions is driving tremendous growth in the field of Digital Therapeutics (DTX) in the Asia Pacific region. To advance the adoption and integration of DTX solutions for better patient outcomes, the Asia Pacific DTX Leadership Alliance is proposed as a collaborative platform to foster innovation, drive adoption, and lead the advancement of Digital Therapeutics across the Asia Pacific region.
Digital Therapeutics is redefining chronic disease management through participative medicine and shared decision-making, and this will be a game-changer for a patient centric healthcare system.
Download the brochure for essential insights into Asia Pacific DTx Leadership Alliance
DownloadObjectives & Activities
- Awareness: Raise awareness among policy makers, industry, clinicians, patients, and the public about the potential benefits and applications of DTX in managing and treating health conditions.
- Advocacy: We will work with the industry and the policy makers to raise awareness among policymakers, healthcare professionals, and the public about the potential benefits of DTX interventions.
- Best Practices: We will collaborate with stakeholders to develop best practice guidelines for boosting the scientific adoption of Digital Therapeutics amongst practitioners.
- Collaboration & Capacity Building: Serve as a unified voice for the recognition and integration of DTX solutions into healthcare systems and regulatory frameworks across the Asia Pacific region. To work with academia and the industry to build capacity for the promising field of Digital Therapeutics.
- Document, Disseminate, Demonstrate and Develop the Market: We will document the success stories and disseminate and demonstrate the benefits to help develop the market for DTX.
- Evidence: Research and generate evidence in the field of DTX to support clinical trials, real-world studies, and outcomes research to generate robust evidence on the effectiveness and value of DTX interventions.
- Foster Innovation and Partnerships: As a leadership alliance, we will help drive the thought leadership for innovation and partnership to enhance the scope and scale of DTX and undertake activities necessary to promote DTX across the region.
Structure of Asia Pacific DTX Leadership Alliance
- DTX Alliance leadership council comprises all founding members who joined from various stakeholder groups. It comprises key leaders nominated by the founding organizations responsible for strategic decision-making, resource allocation, and governance.
- All companies will nominate one representative for the alliance on a rotational basis.
- The members will be part of the alliance on a yearly term basis. The term can be extended based on their interest and contribution to further the objectives of the alliance.
- The members of the alliance will hold quarterly meetings of the stakeholder groups from time to time in different regions.
- We will also invite chapters from different geographical areas led by the founding members.
- The Asia Pacific DTX Leadership Alliance is being hosted by Digital Health Associates through Health Parliament.
*All the decisions will be taken by the Leadership Council and will be final. They will be driving the agenda for the alliance.
-
Founder
Dr. Rajendra Pratap Gupta
-
Chief Mentor
Mr. Bakul Patel
Senior Director, Global Digital Health Strategy & Regulatory, Google
-
Chief Mentor
Dr. Anand Iyer
Chief Analytics Officer, Welldoc Inc., USA (Father of Digital Therapeutics)
-
Chief Mentor
Mr. Abhiroop Gandhi
Former Trust & Compliance Officer, Verily (Google Life Sciences)
-
Vice President
Mr. Zaw Ali Khan
Founder & CEO, Criterion Tech Pvt Ltd
Join the Movement - DTx
- Digital Therapeutics will redefine how we manage chronic patients, and the evidence is mounting in favour of Digital Therapeutics to help in better treatment outcomes. It is imperative that we should be at the forefront of driving the digital transformation of healthcare and make it patient-centric by leveraging the potential of DTX.
- Asia Pacific DTX Leadership Alliance follows a unique ecosystem approach - explicitly catering to the unique needs and challenges of the Asia Pacific region.
- We are focusing on developing a knowledge resource center for DTX. The alliance will create a robust network and a knowledge pool that promotes knowledge creation, sharing, cross-sectoral partnerships, and joint initiatives to advance Digital Therapeutics for improving health outcomes.
- This will remain a membership-led alliance to help shape this promising domain and help the Healthcare - Pharmaceutical Industry to be at the forefront of change.
Membership for Asia Pacific DTx Leadership Alliances
| Membership Type | Eligibility | Benefits | Fees (Excl. Taxes) |
|---|---|---|---|
| Professional / Individual | Individuals / Professionals who have an interest in Digital Therapeutics & Healthcare Technology |
| $50/year |
| Student | Graduate/Postgraduate in Healthcare Domain |
| $25/year |
| Academic / Research | Academic Institutions / Research organizations that are actively engaged in Digital Therapeutics research,education, or innovation |
| $100/year |
| Associate / Startup | Startups / smaller organizations in the Digital Therapeutics space |
| $100/year |
| Corporate / Institutional | Companies / Institutions operating in the Digital Therapeutics & Healthcare Technology |
| $1500/year |
| Founding Members (Exclusive Membership by Invitation only) | Founding members / Pioneers of the alliance |
| $12500 one time + Annual Membership fee as applicable |